• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
PSQ
Click for more information
0.55% $1.83

PACIFIC SMILES GROUP LIMITED - Charts / Financials

Market Cap $291.2M  ! watchlist Created with Sketch. Add to my watchlist
Healthcare

Pacific Smiles Group Limited is an Australia-based dental company. The Company operates... Pacific Smiles Group Limited is an Australia-based dental company. The Company operates dental centers at which independent dentists practice and provide clinical treatments and services to patients. The Company owns and operates the Pacific Smiles Dental and Nib Dental Care centers across the East Coast of Australia and manages the operation of HBF Dental Centers in Western Australia. The Company provides dentists with fully serviced and equipped facilities, including support staff, materials, marketing, and administrative services. The Company operates approximately 120 dental centers nationally. The Company's Dental Center Networks are located in Belconnen, Manuka, Gungahlin and Tuggeranong in Australian Capital Territory (ACT); Ashfield, Belmont and Balgowlah in New South Wales; Caroline Springs and Chirnside Park in Victoria, and Birtinya, Bribie Island and Capalaba in Queensland.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits
refresh Created with Sketch. REFRESH
Last update - 15.58pm 02/10/2024 (20 minute delay) ?
Day
Open $1.83   Day High $1.83   Day Low $1.81
Daily Volume 666472
Bids   Sellers
Number Price Volume   Number Price Volume
1 $1.82 14955   2 $1.84 31664

Directors & Senior Management

Mr. Andrew Vidler Chief Executive Officer, Managing Director, Director
Ms. Belinda Cleminson Company Secretary
Ms. Giselle Collins Non-Executive Chairman of the Board
Mr. Mark Bloom Non-Executive Director
Dr. Scott Kalniz Non-Executive Director
Mr. Andrew Knott Non-Executive Director
Ms. Jodie Lee Leonard Non-Executive Director

Data source: Refinitiv

(20min delay)
Last
$1.83 		Change
0.010(0.55%) 		Mkt cap ! $291.2M
Open High Low Value Volume
$1.83 $1.83 $1.81 $1.212M 666.4K

Buyers (Bids)

No. Vol. Price($)
1 14955 $1.82
 

Sellers (Offers)

Price($) Vol. No.
$1.84 31664 2
View Market Depth
Last trade - 16.10pm 02/10/2024 (20 minute delay) ?
Last
$1.83 		  Change
0.010 ( 0.83 %)
Open High Low Volume
$1.82 $1.83 $1.82 202400
Last updated 15.58pm 02/10/2024 ?

Top Stories

SPC to merge with Original Juice Co and Nature One Dairy

The Original Juice Co Ltd has set up a transaction which will see it merge with Aussie icon SPC Global and Singapore-based Nature One Dairy
Recce eyes Indonesia for novel anti-infective as Indo-Aus ties grow stronger Recce Pharmaceuticals (ASX:RCE) has been on a tear this year. It's developing anti-infective, R327, with clinical results across Diabetic Foot Infection, Acute Bacterial Skin & Skin Structure Infection, and, Urosepsis/UTIs which point to a potential commercial value proposition. It also has a recent key relationship in Indonesia.
Cobalt Blue sees A$60M price tag for Kwinana, WA refinery – but $68M value for stage one Cobalt Blue has released estimates for what it would take to get its proposed Kwinana refinery off the ground, seeing CapEx of $60M.
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.